Search
Primary Biliary Cholangitis Clinical Trials
A listing of 6 Primary Biliary Cholangitis clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 6 of 6
There are currently 6 active clinical trials seeking participants for Primary Biliary Cholangitis research studies. The states with the highest number of trials for Autism participants are Texas, California, Florida and New York.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Are You 55+? Help Test New Technology
Recruiting
Are you in or near Hoboken, NJ? Over 55 years old and willing to look at some cool animations to help test a new artificial intelligence brain technology? Dandelion Science is a neuroscience startup funded by the National Institute of Health exploring new ways to deliver care. You will be compensated for your time in this study. Participation requires a recent eye exam within the past 2 years, or willing to have an exam in our office.
Conditions:
Healthy
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Recruiting
To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
03/19/2024
Locations: Om Research LLC, Lancaster, California +26 locations
Conditions: Primary Biliary Cholangitis
IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA)
Recruiting
To Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects with Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA)
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
03/19/2024
Locations: The Institute for Liver Health II dba Arizona Liver Health, Chandler, Arizona +23 locations
Conditions: Primary Biliary Cholangitis
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
Recruiting
The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Biliary Cholangitis (PBC), and to assess the possible impact on the disease progression of PBC.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/04/2024
Locations: Southern California Research Center, Coronado, California +63 locations
Conditions: Primary Biliary Cholangitis, PBC
Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.
Recruiting
Study to investigate the efficacy and safety of two doses of K-808 (pemafribate) in subjects with PBC.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/30/2024
Locations: Springfield Clinic, Springfield, Illinois +1 locations
Conditions: Primary Biliary Cholangitis
An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)
Recruiting
The Effect of Hepatic Impairment on The Pharmacokinetics of Seladelpar: An Open-Label Study Following Oral Dosing of Seladelpar to Subjects with Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
01/26/2024
Locations: The Institute of Liver Health dba Arizona Liver Health, Chandler, Arizona +17 locations
Conditions: Primary Biliary Cholangitis, Compensated Cirrhosis, Hepatic Impairment
Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis
Recruiting
Saroglitazar Magnesium 1 mg and 2 mg tablets for treatment of subjects with Primary Biliary Cholangitis (PBC)
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
12/30/2023
Locations: Zydus US007, Birmingham, Alabama +56 locations
Conditions: Primary Biliary Cholangitis
1 - 6 of 6